Armata Pharmaceuticals (ARMP) Assets (2013 - 2026)

Armata Pharmaceuticals (ARMP) has 14 years of Assets data on file, last reported at $69.8 million in Q1 2026.

• For the quarter ending Q1 2026, Assets fell 20.0% year-over-year to $69.8 million; the trailing twelve-month figure through Mar 2026 stood at $69.8 million (down 20.0% YoY), and the FY2025 full-year result was $76.9 million, down 11.05% from the prior year.
• Assets retreated to $69.8 million in Q1 2026, from $76.9 million in the prior quarter.
• In the past five years, Assets ranged from a high of $120.4 million in Q1 2024 to a low of $69.8 million in Q1 2026.
• A 5-year average of $96.2 million and a median of $98.2 million in 2024 frame the typical range for Assets.
• Across the five-year window, Assets jumped 117.67% in 2022 and decreased 27.51% in 2025, its largest moves.
• Tracing ARMP's Assets over 5 years: stood at $95.8 million in 2022, then climbed by 2.64% to $98.4 million in 2023, then slipped by 12.12% to $86.4 million in 2024, then slipped by 11.05% to $76.9 million in 2025, then slipped by 9.21% to $69.8 million in 2026.
• Business Quant data shows ARMP's Assets at $69.8 million in Q1 2026, $76.9 million in Q4 2025, and $89.5 million in Q3 2025.